PubMed

Nitric oxide prevents aldose reductase activation and sorbitol accumulation during diabetes.

Chandra D, Jackson EB, Ramana KV, Kelley R, Srivastava SK, Bhatnagar A.

Diabetes. 2002 Oct;51(10):3095-101.PMID: 12351453 [PubMed - indexed for MEDLINE]Related articlesFree article

Nitric oxide regulates the polyol pathway of glucose metabolism in vascular smooth muscle cells.

Ramana KV, Chandra D, Srivastava S, Bhatnagar A, Srivastava SK.

FASEB J. 2003 Mar;17(3):417-25.PMID: 12631581 [PubMed - indexed for MEDLINE]Related articlesFree article

Regulation of lens aldose reductase activity by nitric oxide.

Srivastava S, Tammali R, Chandra D, Greer DA, Ramana KV, Bhatnagar A, Srivastava SK.

Exp Eye Res. 2005 Dec;81(6):664-72. Epub 2005 Jun 20.PMID: 15967436 [PubMed - indexed for MEDLINE]Related articles

Role of nitric oxide in regulating aldose reductase activation in the ischemic heart.

Kaiserova K, Tang XL, Srivastava S, Bhatnagar A.

J Biol Chem. 2008 Apr 4;283(14):9101-12. Epub 2008 Jan 27.PMID: 18223294 [PubMed - indexed for MEDLINE]Related articlesFree article

Regulation of aldose reductase and the polyol pathway activity by nitric oxide.

Srivastava SK, Ramana KV, Chandra D, Srivastava S, Bhatnagar A.

Chem Biol Interact. 2003 Feb 1;143-144:333-40.PMID: 12604220 [PubMed - indexed for MEDLINE]Related articles

Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.

Beyer-Mears A, Ku L, Cohen MP.

Diabetes. 1984 Jun;33(6):604-7.PMID: 6427041 [PubMed - indexed for MEDLINE]Related articles

Pharmacological properties of fidarestat, a potent aldose reductase inhibitor, clarified by using sorbitol in human and rat erythrocytes.

Sobajima H, Aoki T, Sassa H, Suzuki T, Taniko K, Makino M, Mizuno K, Suzuki T.

Pharmacology. 2001 May;62(4):193-9. Erratum in: Pharmacology 2001;63(3):196. Pharmacology 2002 May;65(1):56. PMID: 11359994 [PubMed - indexed for MEDLINE]Related articles

Reduced nerve blood flow in diabetic rats: relationship to nitric oxide production and inhibition of aldose reductase.

Tomlinson DR, Dewhurst M, Stevens EJ, Omawari N, Carrington AL, Vo PA.

Diabet Med. 1998 Jul;15(7):579-85.PMID: 9686698 [PubMed - indexed for MEDLINE]Related articles

Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy.

Mizuno K, Kato N, Makino M, Suzuki T, Shindo M.

J Diabetes Complications. 1999 May-Jun;13(3):141-50.PMID: 10509874 [PubMed - indexed for MEDLINE]Related articles

The effects of aldose reductase inhibition on nerve sorbitol and myoinositol concentrations in diabetic and galactosemic rats.

Yue DK, Hanwell MA, Satchell PM, Handelsman DJ, Turtle JR.

Metabolism. 1984 Dec;33(12):1119-22.PMID: 6438438 [PubMed - indexed for MEDLINE]Related articles

Prevention of urinary albumin excretion in 6 month streptozocin-diabetic rats with the aldose reductase inhibitor tolrestat.

McCaleb ML, Sredy J, Millen J, Ackerman DM, Dvornik D.

J Diabet Complications. 1988 Jan-Mar;2(1):16-8.PMID: 2968349 [PubMed - indexed for MEDLINE]Related articles

Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.

Gillon KR, Hawthorne JN, Tomlinson DR.

Diabetologia. 1983 Oct;25(4):365-71.PMID: 6416913 [PubMed - indexed for MEDLINE]Related articles

Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes.

Amano S, Yamagishi S, Kato N, Inagaki Y, Okamoto T, Makino M, Taniko K, Hirooka H, Jomori T, Takeuchi M.

Biochem Biophys Res Commun. 2002 Nov 29;299(2):183-8.PMID: 12437967 [PubMed - indexed for MEDLINE]Related articles

[Role of polyols in the development of diabetic complications. Value of aldose-reductase inhibitors]

Brogard JM, Caro-Sampara F, Blicklé JF.

Rev Med Interne. 1992 Jan-Feb;13(1):69-79. Review. French. PMID: 1410879 [PubMed - indexed for MEDLINE]Related articles

Sorbinil suppresses glomerular prostaglandin production in the streptozotocin diabetic rat.

Craven PA, DeRubertis FR.

Metabolism. 1989 Jul;38(7):649-54.PMID: 2500578 [PubMed - indexed for MEDLINE]Related articles

Defects of axonal transport in experimental diabetes that are unrelated to the sorbitol pathway.

Tomlinson DR, Willars GB, Calthrop-Owen EF.

Exp Neurol. 1987 Apr;96(1):194-202.PMID: 2435570 [PubMed - indexed for MEDLINE]Related articles

Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study.

Obrosova IG, Fathallah L.

Diabetologia. 2000 Aug;43(8):1048-55.PMID: 10990083 [PubMed - indexed for MEDLINE]Related articles

Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.

Cotter MA, Cameron NE, Hohman TC.

J Peripher Nerv Syst. 1998;3(3):217-23.PMID: 10959252 [PubMed - indexed for MEDLINE]Related articles

Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation.

Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML, et al.

Diabetes. 1993 Feb;42(2):221-32.PMID: 7678825 [PubMed - indexed for MEDLINE]Related articles

Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.

Whiting PH, Ross IS.

Br J Exp Pathol. 1988 Oct;69(5):697-702.PMID: 3143396 [PubMed - indexed for MEDLINE]Related articles